Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 22, Issue 20, 2004, Pages 4165-4173

  Osoegawa, Atsushi ^a   Yoshino, Ichiro ^a   Tanaka, Shinji ^a   Sugio, Kenji ^a   Kameyama, Toshifumi ^a   Yamaguchi, Masafumi ^a   Maehara, Yoshihiko ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; S PHASE KINASE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

AGGRESSIVENESS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL; ADULT; AGED; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENETIC TRANSFECTION; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 7044272500     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.035     Document Type: Article

References (35)

1. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154:313-323, 1999
2. Slingerland J, Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10-17, 2000
3. Kip1 in non-small cell lung carcinoma: A prognostic factor independent of Ras1. Cancer Res 59:684-688, 1999
4. Esposito V, Baldi A, De Luca A, et al: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57:3381-3385, 1997
5. Kip1 correlates with a shortened survival in non-small cell lung cancer. Lung Cancer 34:83-90, 2001
6. Pagano M, Tam S, Theodoras A, et al: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685, 1995
7. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 67:425-479, 1998
8. Gstaiger M, Jordan R, Lim M, et al: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 98:5043-5048, 2001
9. Latres E, Chiarle R, Schulman BA, et al: Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci U S A 98:2515-2520, 2001
10. Kudo Y, Kitajima S, Sato S, et al: High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 61:7044-7047, 2001
11. Masuda T, Inoue H, Sonoda H, et al: Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: Modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62:3819-3825, 2002
12. Hershko D, Bornstein G, Ben-Izhak O, et al: Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Sko2 in colorectal carcinomas. Cancer 91:1745-1751, 2001
13. Chiarle R, Van P, Piva R, et al: S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphomas inversely correlates with p27 expression and defines cells in S-phase. Am J Pathol 160:1457-1466, 2002
14. Yang G, Ayala G, DeMarzo A, et al: Elevated Skp2 protein expression in human prostate cancer: Association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 8:3419-3426, 2002
15. Sigenoretti S, DiMarcotullio L, Richardson A, et al: Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 110:633-641, 2002
16. Yokoi S, Yasui K, Saito-Ohara F, et al: A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 161:207-216, 2002
17. Shigemasa K, Gu L, O'Brien TJ, et al: Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 9:1756-1763, 2003
18. World Health Organization: Histological Typing of Lung and Pleural Tumours (ed 3). Geneva, Switzerland, Springer-Verlag, 1999
19. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111:1710-1717, 1997
20. Carrano AC, Eytan E, Hershko A, et al: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199, 1999
21. Nakayama K, Nagahama H, Minamishima YA, et al: Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 19:2069-2081, 2000
22. Bloom J, Pagano M: Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 13:41-47, 2003
23. Inui N, Kitagawa K, Miwa S, et al: High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun 303:978-984, 2003
24. Zhang H, Kobayashi R, Galaktionov K, et al: P19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82:915-925, 1995
25. Wirbelauer C, Sutterluty H, Blondel M, et al: The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: Evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J 19:5362-5375, 2000
26. Imaki H, Nakayama K, Delehouzee S, et al: Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res 63:4607-4613, 2003
27. Flory E, Hoffmeyer A, Smola U, et al: Raf-1 kinase targets GA-binding protein transcriptional regulation of the human immunodeficiency virus type 1 promoter. J Virol 70:2260-2268, 1996
28. Patten Hitt E, DeLong MJ, Merrill AH Jr: Benzolalpyrene activates extracellular signal-related and p38 mitogen-activated protein kinases in HT29 colon adenocarcinoma cells: Involvement in NAD(P)H:quinone reductase activity and cell proliferation. Toxicol Appl Pharmacol 183:160-167, 2002
29. Harper JW: Protein destruction: Adapting roles for Cks proteins. Curr Biol 11:R431-R435, 2001
30. Kip1. Mol Cell 7:639-650, 2001
31. Hara T, Kamura T, Nakayama K, et al: Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem 276:48937-58943, 2001
32. Tomoda K, Kubota Y, Kato J: Degradation of the cyclin-dependent-kinase inhibitor p27(Kip1) is instigated by Jab1. Nature 398:160-165, 1999
33. von der Lehr N, Johansson S, Wu S, et al: The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11:1189-1200, 2003
34. Kim SY, Herbst A, Tworkowski KA, et al: Skp2 regulates Myc protein stability and activity. Mol Cell 11:1177-1188, 2003
35. Hannon GJ: RNA interference. Nature 418:244-251, 2002